President and CEO Carrie Eglinton Manner spoke to 69 News about what's on the horizon for the Bethlehem-based maker of medical diagnostic testing and collection devices.
Opens in a new tab or window LOS ANGELES -- The FDA's warning about arrhythmia risk with lamotrigine (Lamictal ... patients in a Medicare 20% random sample or the U.K. CALIBER study from primary ...